Matthias B.
- Country
- Germany
- Department
- Neurozentrum Bielefeld
Research Overview
- A Randomized, Double-blind, Parallel-group, Active Controlled Trial with Open-label Safety Extension to Evaluate the Tolerability, Safety, and Efficacy of Atogepant versus Topiramate in Subjects Requiring Preventive Treatment of Migraine (TEMPLE)
- Phase 3 Randomized, Double-Blind Study of Frexalimab (SAR441344) Versus Teriflunomide in Adults with Relapsing Multiple Sclerosis
- Phase 3 Randomized, Double-Blind Study of Frexalimab (SAR441344) Versus Placebo in Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
Data & Insights
Has run more than one trial at 73 of 230 partner sites.
Specializations
Neurological Disorders
This investigator specializes in treating multiple sclerosis, with particular focus on both progressive and relapsing forms of the condition. Their research encompasses innovative therapeutic approaches for managing different manifestations of MS.
- Nonrelapsing Secondary Progressive MS
- Relapsing Forms of MS
- Disability Progression Management
The investigator's work centers on evaluating novel therapeutic agents for multiple sclerosis treatment, particularly focusing on disability progression prevention and relapse rate reduction.
Treatment Innovation
The investigator's research explores comparative therapeutic approaches in multiple sclerosis treatment, examining both novel compounds and established treatments.
- Novel Therapeutic Agents
- Comparative Treatment Studies
- Long-term Disease Management
Their work involves evaluating therapeutic efficacy in different MS presentations, contributing to the advancement of treatment options for patients with various forms of the disease.
Clinical Assessment
The investigator conducts comprehensive evaluations of treatment efficacy and safety in multiple sclerosis therapy, focusing on measurable clinical outcomes.
- Disease Progression Markers
- Treatment Response Assessment
- Safety Profile Evaluation
Their research methodology incorporates detailed assessment of therapeutic interventions in various MS subtypes, emphasizing both effectiveness and patient safety.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.